Rangan R, Petty R, Acharya S, Emmitte K, do Valle R, Lam C
bioRxiv. 2025; .
PMID: 40027829
PMC: 11870397.
DOI: 10.1101/2025.02.13.638188.
Sharova E, Medvedev S
Acta Naturae. 2025; 16(4):48-61.
PMID: 39877007
PMC: 11771839.
DOI: 10.32607/actanaturae.27477.
Sahu V, Lu C
Mol Cell. 2025; 85(2):262-275.
PMID: 39824167
PMC: 11750176.
DOI: 10.1016/j.molcel.2024.12.012.
Zheng Q, Weekley B, Vinson D, Zhao S, Bastle R, Thompson R
Nature. 2025; 637(8047):974-982.
PMID: 39779849
PMC: 11754111.
DOI: 10.1038/s41586-024-08371-3.
Ernst L, Macedo G, McCall L
mSystems. 2025; 10(2):e0003824.
PMID: 39772644
PMC: 11834445.
DOI: 10.1128/msystems.00038-24.
Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis.
Gao Y, Zhang S, Zhang X, Du Y, Ni T, Hao S
iScience. 2024; 27(12):111359.
PMID: 39660050
PMC: 11629229.
DOI: 10.1016/j.isci.2024.111359.
Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy.
Zhou W, Yang F, Zhang X
Cells. 2024; 13(17.
PMID: 39273000
PMC: 11394047.
DOI: 10.3390/cells13171428.
Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression.
Li X, Hu Z, Shi Q, Qiu W, Liu Y, Liu Y
Oncogene. 2024; 43(42):3121-3136.
PMID: 39251845
DOI: 10.1038/s41388-024-03150-w.
Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives.
Wang Y, Zhang M, Xu J, Zheng L, Liu P, Chen J
MedComm (2020). 2024; 5(9):e670.
PMID: 39184862
PMC: 11344282.
DOI: 10.1002/mco2.670.
Chromosomal instability as a driver of cancer progression.
Chen X, Agustinus A, Li J, DiBona M, Bakhoum S
Nat Rev Genet. 2024; 26(1):31-46.
PMID: 39075192
DOI: 10.1038/s41576-024-00761-7.
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight.
Li A, Wang R, Zhao Y, Zhao P, Yang J
Metabolites. 2024; 14(6).
PMID: 38921460
PMC: 11205353.
DOI: 10.3390/metabo14060325.
Applying multi-omics toward tumor microbiome research.
Zhang N, Kandalai S, Zhou X, Hossain F, Zheng Q
Imeta. 2024; 2(1):e73.
PMID: 38868335
PMC: 10989946.
DOI: 10.1002/imt2.73.
ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7.
Zhang M, Cai F, Guo J, Liu S, Ma G, Cai M
Cell Death Dis. 2024; 15(4):297.
PMID: 38670954
PMC: 11053133.
DOI: 10.1038/s41419-024-06666-x.
The Noncanonical Functions of Metabolites in Tumor Progression.
Wu S, Qi Y, Yang W
Metabolites. 2024; 14(3).
PMID: 38535331
PMC: 10972154.
DOI: 10.3390/metabo14030171.
Epigenetic marks or not? The discovery of novel DNA modifications in eukaryotes.
Meng W, Wang Z, Zhang Y, Hou Y, Xue J
J Biol Chem. 2024; 300(4):106791.
PMID: 38403247
PMC: 11065753.
DOI: 10.1016/j.jbc.2024.106791.
ROS: Executioner of regulating cell death in spinal cord injury.
Yin Z, Wan B, Gong G, Yin J
Front Immunol. 2024; 15:1330678.
PMID: 38322262
PMC: 10844444.
DOI: 10.3389/fimmu.2024.1330678.
Epigenetic meets metabolism: novel vulnerabilities to fight cancer.
Scumaci D, Zheng Q
Cell Commun Signal. 2023; 21(1):249.
PMID: 37735413
PMC: 10512595.
DOI: 10.1186/s12964-023-01253-7.
DJ-1 paralogs maintain genome integrity through glycation repair of nucleic acids and proteins.
Susarla G, Kataria P, Kundu A, DSilva P
Elife. 2023; 12.
PMID: 37548361
PMC: 10431920.
DOI: 10.7554/eLife.88875.
The Tale of DJ-1 (PARK7): A Swiss Army Knife in Biomedical and Psychological Research.
Sun M, Zheng Q
Int J Mol Sci. 2023; 24(8).
PMID: 37108572
PMC: 10138432.
DOI: 10.3390/ijms24087409.
Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy.
Padinharayil H, Rai V, George A
Cancers (Basel). 2023; 15(4).
PMID: 36831413
PMC: 9954550.
DOI: 10.3390/cancers15041070.